The First Clinical Trial is Approaching

Adrian Harel (adrian.harel a, Aug 1st 2016

Medicortex is planning to conduct a clinical trial in the Q4 of 2016. The presence and the profiles of the unique biomarkers will be studied and compared between head injured patients and healthy volunteers. The study will be performed in collaboration with the Turku University Hospital (Tyks), and the project will be funded by The Finnish Funding Agency for Innovation (Tekes, 70%) and private investors (30%).